Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 43
MetricValuePeriodScopeSource row
Revenue¥1.3bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥2.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income−¥149m2024-04-01 → 2024-09-30Cons.Operating income
Operating income−¥242m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income−¥103m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥40m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥70m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax−¥103m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥62m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)−¥104m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥31m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥61m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income−¥104m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥61m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥9.4bnat 2024-09-30Cons.Assets
Total assets¥9.1bnat 2024-03-31Cons.Assets
Total assets¥8.4bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥679mat 2024-09-30Cons.Liabilities
Total liabilities¥741mat 2024-03-31Cons.Liabilities
Net assets / equity¥8.7bnat 2024-09-30Cons.Net assets
Net assets / equity¥8.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥7.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥3.0bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥2.9bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥3.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow−¥131m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥11m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥58m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥412m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥404m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥46m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥681m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥544m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-1.142024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.372023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.712023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio92.8%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio91.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2024-04-01 → 2024-09-30−¥378m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥176m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥176m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥8m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥1.1bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.1bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥267m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.3bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.3bn
—segment totalsegment ordinary income2024-04-01 → 2024-09-30¥275m
Reconciling Itemsreconcilingsegment ordinary income2023-04-01 → 2023-09-30−¥214m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥110m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥174m
—segment totalrevenue2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.1bn
—segment totalsegment ordinary income2023-04-01 → 2023-09-30¥284m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 483
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)監査法人Bloom
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)中塚  亨
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)福田 素裕
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration1147139000JPY
Net sales (5-year summary)CurrentYTDDuration1320413000JPY
Net sales (5-year summary)Prior1YearDuration2426817000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration70276000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration-103257000JPY
Ordinary income loss (5-year summary)Prior1YearDuration40191000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration60802000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration-104219000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration-31415000JPY
Comprehensive income (5-year summary)Prior1YTDDuration169220000JPY
Comprehensive income (5-year summary)CurrentYTDDuration-249246000JPY
Comprehensive income (5-year summary)Prior1YearDuration136095000JPY
Net assets (5-year summary)Prior1QuarterInstant7744442000JPY
Net assets (5-year summary)CurrentQuarterInstant8743058000JPY
Net assets (5-year summary)Prior1YearInstant8311593000JPY
Total assets (5-year summary)Prior1QuarterInstant8408314000JPY
Total assets (5-year summary)CurrentQuarterInstant9422557000JPY
Total assets (5-year summary)Prior1YearInstant9052627000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration0.71
Basic earnings loss per share (5-year summary)CurrentYTDDuration-1.14
Basic earnings loss per share (5-year summary)Prior1YearDuration-0.37
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.921
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.928
Equity to asset ratio (5-year summary)Prior1YearInstant0.918
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration58231000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration-131156000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration-11451000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration46220000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration-412042000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration404424000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration-JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration680711000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration544050000JPY
Cash and cash equivalents (5-year summary)Prior1QuarterInstant2085379000JPY
Cash and cash equivalents (5-year summary)CurrentQuarterInstant3046249000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant2939057000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember94331891
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember94331891
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant94331891
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant94331891
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember1694444
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.0179

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass